207 related articles for article (PubMed ID: 2670487)
21. Oxyntomodulin and its (19-37) and (30-37) fragments inhibit histamine-stimulated gastric acid secretion in the conscious rat.
Carles-Bonnet C; Jarrousse C; Niel H; Martinez J; Bataille D
Eur J Pharmacol; 1991 Oct; 203(2):245-52. PubMed ID: 1800120
[TBL] [Abstract][Full Text] [Related]
22. Gastric emptying and release of incretin hormones after glucose ingestion in humans.
Schirra J; Katschinski M; Weidmann C; Schäfer T; Wank U; Arnold R; Göke B
J Clin Invest; 1996 Jan; 97(1):92-103. PubMed ID: 8550855
[TBL] [Abstract][Full Text] [Related]
23. Effect of motilin on the rate of gastric emptying and gut hormone release during breakfast.
Christofides ND; Modlin IM; Fitzpatrick ML; Bloom SR
Gastroenterology; 1979 May; 76(5 Pt 1):903-7. PubMed ID: 374176
[TBL] [Abstract][Full Text] [Related]
24. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
Schirra J; Nicolaus M; Roggel R; Katschinski M; Storr M; Woerle HJ; Göke B
Gut; 2006 Feb; 55(2):243-51. PubMed ID: 15985560
[TBL] [Abstract][Full Text] [Related]
25. A pure enteroglucagon, oxyntomodulin (glucagon 37), stimulates insulin release in perfused rat pancreas.
Jarrousse C; Bataille D; Jeanrenaud B
Endocrinology; 1984 Jul; 115(1):102-5. PubMed ID: 6376068
[TBL] [Abstract][Full Text] [Related]
26. Oxyntomodulin and its C-terminal octapeptide inhibit liquid meal-stimulated acid secretion.
Jarrousse C; Niel H; Audousset-Puech MP; Martinez J; Bataille D
Peptides; 1986; 7 Suppl 1():253-6. PubMed ID: 3748850
[TBL] [Abstract][Full Text] [Related]
27. Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans.
Schirra J; Houck P; Wank U; Arnold R; Göke B; Katschinski M
Gut; 2000 May; 46(5):622-31. PubMed ID: 10764704
[TBL] [Abstract][Full Text] [Related]
28. Oxyntomodulin (glicentin-(33-69)): pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs.
Baldissera FG; Holst JJ; Knuhtsen S; Hilsted L; Nielsen OV
Regul Pept; 1988 May; 21(1-2):151-66. PubMed ID: 2839871
[TBL] [Abstract][Full Text] [Related]
29. Dual effect of bombesin and gastrin releasing peptide on gastric emptying in conscious cats.
Chikh-Issa AR; Scarpignato C; Collinet M; Chayvialle JA; Vagne M
Peptides; 1989; 10(2):281-7. PubMed ID: 2755871
[TBL] [Abstract][Full Text] [Related]
30. Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): a potent inhibitor of pentagastrin-stimulated acid secretion in rats.
Dubrasquet M; Bataille D; Gespach C
Biosci Rep; 1982 Jun; 2(6):391-5. PubMed ID: 6125221
[No Abstract] [Full Text] [Related]
31. Perturbation of gastric emptying and duodenal motility through the central nervous system.
Thompson DG; Richelson E; Malagelada JR
Gastroenterology; 1982 Dec; 83(6):1200-6. PubMed ID: 7129028
[TBL] [Abstract][Full Text] [Related]
32. The gastric acid secretagogue gastrin-releasing peptide and the inhibitor oxyntomodulin do not exert their effect directly on the parietal cell in the rat.
Gehl J; Jeppesen JL; Poulsen SS; Holst JJ
Digestion; 1988; 40(3):144-51. PubMed ID: 3234620
[TBL] [Abstract][Full Text] [Related]
33. Action of intravenous ethanol and atropine on the secretion of gastric acid, pancreatic enzymes, and bile acids and the motility of the upper gastrointestinal tract in nonalcoholic humans.
Kölbel CB; Singer MV; Möhle T; Heinzel C; Eysselein V; Goebell H
Pancreas; 1986; 1(3):211-8. PubMed ID: 2437566
[TBL] [Abstract][Full Text] [Related]
34. Role of lipase in the regulation of upper gastrointestinal function in humans.
Schwizer W; Asal K; Kreiss C; Mettraux C; Borovicka J; Rémy B; Güzelhan C; Hartmann D; Fried M
Am J Physiol; 1997 Sep; 273(3 Pt 1):G612-20. PubMed ID: 9316463
[TBL] [Abstract][Full Text] [Related]
35. Postprandial normal saline intake delays gastric emptying of solids in conscious dogs: partial involvement of CCK in its mechanism.
Tanaka T; Mizumoto A; Muramatsu S; Mochiki E; Haga N; Suzuki H; Itoh Z
Dig Dis Sci; 1999 Aug; 44(8):1516-24. PubMed ID: 10492127
[TBL] [Abstract][Full Text] [Related]
36. Pentagastrin-stimulated gastric acid output and plasma enteroglucagon in acarbose-treated rats.
Rolston R; Ghiglione M; Bacarese-Hamilton AJ; Uttenthal LO; Bloom SR
Digestion; 1985; 32(2):124-7. PubMed ID: 3899816
[TBL] [Abstract][Full Text] [Related]
37. Abnormal plasma gut hormones in pathologic duodenogastric reflux and their response to surgery.
Wilson P; Welch NT; Hinder RA; Anselmino M; Herrington MK; DeMeester TR; Adrian TE
Am J Surg; 1993 Jan; 165(1):169-76; discussion 176-7. PubMed ID: 8418694
[TBL] [Abstract][Full Text] [Related]
38. Clinical relevance of gastroduodenal dysfunction in reflux esophagitis.
Dubois A
J Clin Gastroenterol; 1986; 8 Suppl 1():17-25. PubMed ID: 3090134
[TBL] [Abstract][Full Text] [Related]
39. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.
Kuo P; Stevens JE; Russo A; Maddox A; Wishart JM; Jones KL; Greville H; Hetzel D; Chapman I; Horowitz M; Rayner CK
J Clin Endocrinol Metab; 2011 May; 96(5):E851-5. PubMed ID: 21389144
[TBL] [Abstract][Full Text] [Related]
40. Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion.
Witte AB; Grybäck P; Jacobsson H; Näslund E; Hellström PM; Holst JJ; Hilsted L; Schmidt PT
Scand J Gastroenterol; 2011 Apr; 46(4):428-35. PubMed ID: 21114428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
